Newscenter Media News New research shows GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, published in the peer-reviewed journal Thyroid, the official journal of the American Thyroid Association, found no evidence linking the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) to an increased risk of thyroid cancer. What are GLP1-RAs? […] Read More
Check Also
Webb Spots Ancient Galaxy Breaking Through the Universe’s Primordial Fog
Astronomers have found early evidence of the Universe’s transformation from a foggy, opaque state to …